Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Bone Biologics Corporation develops recombinant human protein-based medical devices for bone regeneration, focusing on spinal fusion using its proprietary NELL-1 protein combined with demineralized bone matrix (DBM). Targeting orthopedic and spinal surgery markets, the company’s platform aims to improve bone growth outcomes with a safer, targeted approach. Its business model centers on clinical development, regulatory approval, and commercialization of osteopromotive biologics for surgeons and patients with bone defects.
This description was generated via AI from an annual report. Updated about 1 year ago.